波士顿科学Boston Scientific Corporation (BSX) 2021年年度报告「NYSE」.pdf

1、2021 Annual ReportBoston Scientific Corporation300 Boston Scientific WayMarlborough,MA 01752- 2022 Boston Scientific Corporation or its affiliates.All rights reserved.AR2021Boston Scientific 2021 Annual Report25687_A_BSC_AR_Cover.indd 125687_A_BSC_AR_Cover.indd 13/15/22 9:26 PM3/15/22 9:26 PM Dear S

2、tockholders:Boston Scientific performed strongly in 2021.Amid significant disruption,our global team proved its resilience by navigating uncertainty with agility,developing new capabilities and turning challenges into opportunities.Throughout the year,with each stage of the pandemic having a smaller

3、 impact on our business,we supported health care systems,physicians,communities and one another.And,most important to our mission,Boston Scientific helped improve the lives of more than 30 million patients.Throughout the year we challenged whats possible.This winning spirit led us to launch 145 new

4、clinical trials,introduce 90 innovative products and enhance our digital capabilities.We kept our focus on organic innovation and business development deals to support our category leadership strategy,including the acquisition of five companies in the past year that expand our portfolio and compleme

5、nt our existing medical technologies.We invested in our growth while continuing to work on minimizing our impact on the environment and advancing our diversity,equity and inclusion(DE&I)goals.And around the world we supported local communities through health equity initiatives and more than 50,000 v

6、olunteer hours in more than 50 countries.We are stronger for the hurdles we have overcome.While we will continue to face challenges,our business and our talented team of employees are well-positioned for the future.2021 ResultsThe global strength of our product diversification and category leadershi